Faeth Therapeutics, Inc. SEC filings FTH
Faeth Therapeutics, Inc. has 452 filings in SEC EDGAR's recent list, going back to Nov 12, 2020. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | May 22, 2026 | — |
| DEFA14A | Additional proxy material | May 21, 2026 | — |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 10, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2026 | Jun 10, 2026 |
| DEFA14A | Additional proxy material | Apr 11, 2025 | — |
| DEF 14A | Proxy statement | Apr 11, 2025 | May 21, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 1, 2025 | May 21, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 11, 2024 |
| DEF 14A | Proxy statement | Jun 15, 2023 | Jul 10, 2023 |
| DEFA14A | Additional proxy material | May 23, 2023 | — |
| DEFA14A | Additional proxy material | Mar 10, 2023 | — |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEF 14A | Proxy statement | Apr 28, 2022 | Jun 10, 2022 |
Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- FTH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Austin, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1829802
- Former names
- Sensei Biotherapeutics, Inc. (until Jun 16, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.